RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancer

Agnieszka K. Witkiewicz, Adam Ertel, Jeanne McFalls, Matias E. Valsecchi, Gordon Schwartz, Erik S. Knudsen

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences